Cancer Research

The landscape of cancer treatment has undergone a radical transformation as the medical community realizes that traditional screening methods often leave high-risk individuals in the shadows. Precision oncology is shifting toward a model where every adult diagnosed with a solid tumor receives

Combining CAR-M with checkpoint inhibitors such as PD-1 blockers creates a multi-pronged therapeutic strategy that addresses the biological complexity of solid tumors more effectively than monotherapy. The landscape of precision medicine is shifting as chimeric antigen receptor technologies evolve

The metabolic fitness of manufactured immune cells is a crucial metric, as exhausted cells lose their ability to persist once injected into a patient. Glioblastoma multiforme remains a relentless adversary in the field of neuro-oncology, characterized by its rapid progression and an almost

Biohybrid systems integrate living biological components like Spirulina algae with synthetic iron oxide to create steerable platforms for photothermal therapy. This innovative approach addresses a long-standing challenge in oncology, where traditional chemotherapy often acts like a blunt

Clinical investigators are utilizing the follicle-stimulating hormone itself as a targeting mechanism to guide engineered T-cells directly to the FSHR-expressing ovarian tumor cells. This innovative approach, known as liraltagene autoleucel or lira-cel, represents a pivotal shift in how oncologists

The current clinical movement toward active surveillance for low-risk thyroid nodules is frequently hampered by the inability to detect occult metastasis using traditional imaging techniques. While modern medical guidelines encourage monitoring small, indolent papillary thyroid carcinomas to avoid